We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Trial Opens In Glaxo's Lamictal Patent Suit

Law360 (January 18, 2005, 12:00 AM EST) -- U.K. drug maker GlaxoSmithKline Plc’s patent lawsuit against Israeli generics maker Teva Pharmaceutical Industries Ltd. over its best-selling anti-epileptic drug Lamictal will be heard in a U.S. court on Tuesday....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.